Journals in Lipids and lipid metabolism

Atherosclerosis

ISSN: 0021-9150
5 Year impact factor: 5.3
Impact factor: 4.9

Cardiovascular disease (CVD) causes one third of all deaths worldwide and is a major threat to global health. Atherosclerosis aims to provide a comprehensive platform for researchers, clinicians and healthcare professionals to share the latest findings and advances in the field of atherosclerosis. Atherosclerosis covers a wide range of topics, including:Pathophysi... and Mechanisms: We explore the intricate cellular and molecular processes involved in atherogenesis, from the initial formation of fatty streaks to the development of complex plaques. We also welcome studies on cardiac biology and disease.Risk Factors: We consider manuscripts that examine both traditional and emerging risk factors for atherosclerosis, such as dyslipidaemia, hypertension, diabetes mellitus, thrombosis and genetic predisposition.Preve... of CVD: Since prevention will become a major focus in the future (see e.g. the European Cardiovascular Health Plan), an important focus will be on preventive strategies, including lifestyle modifications and pharmacological interventions.Diagno... Techniques: We features articles on cutting-edge diagnostic techniques, ranging from invasive procedures such as selective coronary arteriography to non-invasive techniques such as blood biomarkers.Treatment Approaches: Atherosclerosis covers the latest developments in the treatment of atherosclerosis, including lipid-lowering therapies, anti-inflammatory treatments and novel targeted approaches aimed at modifying disease progression and improving clinical outcomes.Translation... Research: We bridges the gap between basic science and clinical practice by highlighting translational studies that bring laboratory findings closer to practical applications in patient care.By fostering collaboration and knowledge exchange between researchers and clinicians, Atherosclerosis aims to accelerate progress in the understanding, prevention and treatment of atherosclerosis, ultimately improving the lives of the millions of people affected by this pervasive disease.

Subscriptions

Biochimica et Biophysica Acta: Biomembranes

ISSN: 0005-2736
5 Year impact factor: 3.2
Impact factor: 2.8

BBA Biomembranes has its main focus on membrane structure, function and biomolecular organization, membrane proteins, receptors, channels and anchors, fluidity and composition, model membranes and liposomes, membrane surface studies and ligand interactions, transport studies, and membrane dynamics.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscriptions

Biochimica et Biophysica Acta: Molecular Basis of Disease

ISSN: 0925-4439
5 Year impact factor: 5.5
Impact factor: 4.2

BBA Molecular Basis of Disease addresses the biochemistry and molecular genetics of disease processes and models of human disease.Manuscripts should emphasize the underlying molecular mechanisms of human disease pathways and provide significant advances to the understanding and/or treatment of these disorders.Studies in model organisms or systems are strongly recommended in order to validate mechanistic insights. Topics of interest include, but are not limited toAgingCancerCardiov... diseasesCell death–related diseasesGenetic diseasesGenetic and epigenetic regulation in diseasesImmunologica... diseasesInflammatory diseasesMetabolic diseasesMitochondria... diseasesMuscular diseasesNeurological diseasesThe non-preferred topics for BBADIS includeNon-coding RNAsResearch on non-coding RNAs (microRNAs, lncRNAs, circRNAs, etc.) will be considered only if it provides significantly novel insights into disease mechanisms.Single Cell Line StudiesStudies involving single cell lines will be considered only if they present significantly novel findings.Computation... (in Silico) StudiesPurely computational works (e.g., Mendelian randomization, molecular docking, molecular dynamics) will generally be declined unless they provide novel insights into disease mechanisms.Disease BiomarkersResearch on disease biomarkers will be considered only if it relates to the explanation of disease mechanisms.Descripti... or Correlative StudiesDescriptive or correlative studies (e.g., up/down regulation of gene products, -omics studies without follow-up experiments) will be declined unless they provide mechanistic insights.Natural Products and Traditional MedicineWork on natural products, extracts, and traditional medicine will be considered only if single biochemical components are characterized and tested.Clinical Studies and Case ReportsClinical studies or case reports without mechanistic insights are outside the scope of the journal.Hypothesis ArticlesSubmissions based solely on hypotheses will not be considered.Comparati... Genomics StudiesComparative genomics studies (e.g., GWAS) will only be considered if they provide specific insights into the structural and/or functional properties of individual genes.Incremental WorkResearch that offers incremental advancements without significant novelty or impact will generally be declined.

Subscriptions

Biochimica et Biophysica Acta: Molecular and Cell Biology of Lipids

ISSN: 1388-1981
5 Year impact factor: 4.3
Impact factor: 3.9

BBA Molecular and Cell Biology of Lipids publishes papers on original research dealing with novel aspects of lipid biology including the biosynthesis, degradation, and transport of lipids, the role of lipids and the lipidome in cells and whole organisms, and the regulation of lipid metabolism and function in normative health and disease states.Manuscripts should significantly advance the understanding of the molecular mechanisms underlying biological processes in which lipids are involved using biochemical, biophysical, cell and molecular biological, genetic, or physiological approaches. Papers detailing novel methodology should also include biochemical, molecular, or functional insight in the area of lipids. Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscriptions

Cellular Signalling

ISSN: 0898-6568
5 Year impact factor: 4.4
Impact factor: 4.4

Cellular Signalling publishes original research describing fundamental and clinical findings on the mechanisms, actions and structural components of cellular signalling systems in vitro and in vivo.Cellular Signalling aims at full length research papers defining signalling systems ranging from microorganisms to cells, tissues and higher organisms.Cellular Signalling strives to offer a fair and fast peer-review process with a single round of revisions. Reviews are by invitation-only. Short Reports are not accepted.

Subscriptions

Endocrine Practice

ISSN: 1530-891X
5 Year impact factor: 3.6
Impact factor: 3.7

Endocrine Practice, the flagship journal of the American Association of Clinical Endocrinology, is a double-blind, peer-reviewed journal publishing the latest clinical information on the treatment of diabetes, nutrition and obesity, thyroid disease, bone and parathyroid disease, lipid and cardiovascular health, and pituitary, gonad, adrenal, and neuroendocrine disorders.The journal is intended to enhance the clinical knowledge, treatment, and management of pediatric and adult endocrine diseases for the endocrinologist and endocrine care community, and publishes original research, clinical trials, reviews, commentaries, and editorials. Special articles include AACE's clinical guidance documents: clinical practice guidelines, consensus statements, and treatment algorithms.

Subscriptions

Progress in Lipid Research

ISSN: 0163-7827
5 Year impact factor: 15.7
Impact factor: 14

Publishing Invited ReviewsThe importance of lipids as one of the fundamental classes of biological compounds is well established. The application of our of the biochemistry, chemistry and physiology of lipids to biotechnology, the fats and oils industry and medicine have continued to expand apace. In addition new dimensions such as lipid biophysics, especially with relevance to membranes and lipoproteins, and basic liposome research and applications have been added. To cope with all these advances in knowledge a journal is needed to review recent progress in particular fields and to set current research against its historical background. Progress in Lipid Research fulfils this role.Each volume contains up-to-date surveys of special aspects of lipid research. The invited reviews are comprehensive enough to provide sufficient overview but concentrate on reporting and critically appraising the most recent data. Subjects are chosen for their timeliness or because major developments have taken place in the last few years. They include methodological reviews as well as chemical, biochemical and medical articles. All lipid compounds and derivatives are covered, ranging from fatty acids and other simple molecules, through steroids, terpenoids and phospho- or glycolipids to complex structures such as lipoproteins and biological membranes. We hope that those whose main interest is in lipid biophysics and liposome research will join as new readers, benefiting from the journal's classical aspects of lipid metabolism, lipids in signal transduction and lipid enzymology, and that current readers will benefit from the exposure to top quality research on the new aspects.PLR solely publishes review articles, and submissions are by invitation only. If you have not been invited, but would like to have a review article considered, please send your proposal to the Editorial Office (Mrs. Andy Deelen at [email protected]... thereby indicating which editor has the most appropriate expertise to handle the manuscript. Proposals must include a short abstract, proposed table of contents/chapters, a representative figure (if relevant), and a list of key references. Also provide the following information for all co-authors: affiliations, email addresses, and ORCID iDs. If possible, please supply a timeline for submission of your article. After assessment of the proposal by the Editors, we will let you know whether it is suitable for inclusion in the journal.Editors and their expertise:Makoto Arita: Polyunsaturated fatty acid (PUFA)-derived mediators; LC-MS/MS-based lipidomics; role of lipid mediators in inflammation and tissue homeostasis; eosinophils; cyclooxygenases, lipoxygenases, and cytochrome P450 monooxygenases. Gwendolyn Barceló-Coblijn: Metabolism, Oncology, Lipid Analytical Techniques, mass spectrometry imaging. Kent Chapman: Plant lipid metabolism; plant lipid signaling; membranes; oilseeds; lipid storage; compartmentalization... organelle biogenesis; lipid analysis. Gabor Tigyi: Lysophospholipids, lysophosphatidic acid, sphingosine-1-phosph... lipid signaling, radiation biology, drug discovery.

Subscriptions

Prostaglandins & Other Lipid Mediators

ISSN: 1098-8823
5 Year impact factor: 2.8
Impact factor: 2.5

Prostaglandins & Other Lipid Mediators is the original and foremost journal dealing with prostaglandins and related lipid mediator substances. It includes basic and clinical studies related to the pharmacology, physiology, pathology and biochemistry of lipid mediators.Prostaglan... & Other Lipid Mediators invites reports of original research, mini-reviews, reviews, and methods articles in the basic and clinical aspects of all areas of lipid mediator research: cell biology, developmental biology, genetics, molecular biology, chemistry, biochemistry, physiology, pharmacology, endocrinology, biology, the medical sciences, and epidemiology.Prostag... & Other Lipid Mediators also accepts proposals for special issue topics. The Editors will make every effort to advise authors of the decision on the submitted manuscript within 3-4 weeks of receipt.US National Institutes of Health (NIH) voluntary posting ("Public Access") policy Prostaglandins & Other Lipid Mediators and Elsevier facilitate the author's response to the NIH Public Access Policy. For more details please see the Guide for authorsBenefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscriptions

Trends in Cardiovascular Medicine

ISSN: 1050-1738
5 Year impact factor: 7.3
Impact factor: 7.3

Trends in Cardiovascular Medicine provides in depth state-of-the-art reviews of scientific advances in cardiovascular medicine, written and critiqued by internationally known experts. Articles present an authoritative understanding on a range of topics, including basic mechanisms, diagnosis, treatment, and prognosis of heart and blood vessel disorders for clinicians and basic scientists. Topics offer insights into all aspects of cardiology, ranging from arrhythmias to vasculopathies.

Subscriptions

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health

Journals in Lipids and lipid metabolism

Atherosclerosis

Biochimica et Biophysica Acta: Biomembranes

Biochimica et Biophysica Acta: Molecular Basis of Disease

Biochimica et Biophysica Acta: Molecular and Cell Biology of Lipids

Cellular Signalling

Endocrine Practice

Progress in Lipid Research

Prostaglandins & Other Lipid Mediators

Trends in Cardiovascular Medicine